Motto International Rhino Platinum Capsules Recall: FDA Class I

Why it was recalled

Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil

Product description

Rhino 7 Platinum 30000 Capsules, in blue,orange,black background with red,white,blue,gray text in hologram paper packaging, packaged in 2, 4, and 10 count blister cards, Motto International, Dallas, TX

Lot numbers, UPCs & expiration codes

All lots remaining within expiry.

Where it was sold

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-0656-2020
Classification: Class I
Status: Terminated
Recall initiated: Dec 17, 2019
FDA report date: Jan 22, 2020
Quantity: 5 boxes
Recall type: Voluntary: Firm initiated
Recalling firm: Motto International Corp

Original FDA data

Every field from FDA enforcement report D-0656-2020, exactly as published.

Show all FDA fields

City: Dallas
State: TX
Status: Terminated
Country: United States
Event ID: 84526
Address: 1908 Royal Ln Ste 700
Code information: All lots remaining within expiry.
Postal code: 75229-0269
Report date: Jan 22, 2020
Product type: Drugs
Recall number: D-0656-2020
Classification: Class I
Recalling firm: Motto International Corp
Product quantity: 5 boxes
Termination date: Oct 29, 2021
Reason for recall: Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
Voluntary / mandated: Voluntary: Firm initiated
Product description: Rhino 7 Platinum 30000 Capsules, in blue,orange,black background with red,white,blue,gray text in hologram paper packaging, packaged in 2, 4, and 10 count blister cards, Motto International, Dallas, TX
Distribution pattern: TX
Recall initiation date: Dec 17, 2019
Initial firm notification: Press Release
Center classification date: Jan 10, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0656-2020, published Jan 22, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

Motto International Rhino 7 Platinum 30000 Capsules Recall

Summary